Skip to main content
Top
Published in: BMC Pregnancy and Childbirth 1/2024

Open Access 01-12-2024 | Diabetes | Research

Diabetes mellitus in pregnancy across Canada

Authors: Chantal RM Nelson, Susie Dzakpasu, Aideen M. Moore, Elizabeth K. Darling, Wesley Edwards, Phil Murphy, Heather Scott, Michiel Van Den Hof, Joel G. Ray

Published in: BMC Pregnancy and Childbirth | Issue 1/2024

Login to get access

Abstract

Background

Contemporary estimates of diabetes mellitus (DM) rates in pregnancy are lacking in Canada. Accordingly, this study examined trends in the rates of type 1 (T1DM), type 2 (T2DM) and gestational (GDM) DM in Canada over a 15-year period, and selected adverse pregnancy outcomes.

Methods

This study used repeated cross-sectional data from the Canadian Institute of Health Information (CIHI) hospitalization discharge abstract database (DAD). Maternal delivery records were linked to their respective birth records from 2006 to 2019. The prevalence of T1DM, T2DM and GDM were calculated, including relative changes over time, assessed by a Cochrane-Armitage test. Also assessed were differences between provinces and territories in the prevalence of DM.

Results

Over the 15-year study period, comprising 4,320,778 hospital deliveries in Canada, there was a statistically significant increase in the prevalence of GDM and T1DM and T2DM. Compared to pregnancies without DM, all pregnancies with any form of DM had higher rates of hypertension and Caesarian delivery, and also adverse infant outcomes, including major congenital anomalies, preterm birth and large-for-gestational age birthweight.

Conclusion

Among 4.3 million pregnancies in Canada, there has been a rise in the prevalence of DM. T2DM and GDM are expected to increase further as more overweight women conceive in Canada.
Appendix
Available only for authorised users
Literature
2.
go back to reference Canada. PHA of. Perinatal Health Report. Ottawa, ON: Government of Canada; 2013. Canada. PHA of. Perinatal Health Report. Ottawa, ON: Government of Canada; 2013.
3.
go back to reference Imperatore G, Boyle JP, Thompson TJ, Case D, Dabelea D, Hamman RF, et al. Projections of type 1 and type 2 diabetes burden in the U.S. population aged < 20 years through 2050: dynamic modeling of incidence, mortality, and population growth. United States. 2012;35:2515–20. Imperatore G, Boyle JP, Thompson TJ, Case D, Dabelea D, Hamman RF, et al. Projections of type 1 and type 2 diabetes burden in the U.S. population aged < 20 years through 2050: dynamic modeling of incidence, mortality, and population growth. United States. 2012;35:2515–20.
7.
go back to reference Stanhope KK, Joseph NT, Platner M, Hutchison C, Wen S, Laboe A, et al. Validation of ICD-10 codes for gestational and pregestational diabetes during pregnancy in a large, Public Hospital. Volume 32. United States: Wolters Kluwer Health, Inc; 2021. pp. 277–81. Stanhope KK, Joseph NT, Platner M, Hutchison C, Wen S, Laboe A, et al. Validation of ICD-10 codes for gestational and pregestational diabetes during pregnancy in a large, Public Hospital. Volume 32. United States: Wolters Kluwer Health, Inc; 2021. pp. 277–81.
10.
go back to reference Mobasseri M, Shirmohammadi M, Amiri T, Vahed N, Hosseini Fard H, Ghojazadeh M. Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis. Maad Rayan Publishing Company; 2020. p. 98. Mobasseri M, Shirmohammadi M, Amiri T, Vahed N, Hosseini Fard H, Ghojazadeh M. Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis. Maad Rayan Publishing Company; 2020. p. 98.
11.
go back to reference Kramer MS, Platt RW, Wen SW, Joseph KS, Allen A, Abrahamowicz M et al. A new and improved population-based Canadian reference for birth weight for gestational age. 2001;108:E35. Kramer MS, Platt RW, Wen SW, Joseph KS, Allen A, Abrahamowicz M et al. A new and improved population-based Canadian reference for birth weight for gestational age. 2001;108:E35.
13.
go back to reference Berger H, Gagnon R, Sermer M, Guideline. No 393-Diabetes Pregnancy. 2019;41:1814–25. e1. Berger H, Gagnon R, Sermer M, Guideline. No 393-Diabetes Pregnancy. 2019;41:1814–25. e1.
17.
go back to reference Shojaeian A. An overview of the Epidemiology of Type 1 Diabetes Mellitus. 2018. Shojaeian A. An overview of the Epidemiology of Type 1 Diabetes Mellitus. 2018.
19.
go back to reference Bancej C, Jayabalasingham B, Wall RW, Rao DP, Do MT, de Groh M, et al. Evidence brief–trends and projections of obesity among canadians. Canada. 2015;35:109–12. Bancej C, Jayabalasingham B, Wall RW, Rao DP, Do MT, de Groh M, et al. Evidence brief–trends and projections of obesity among canadians. Canada. 2015;35:109–12.
23.
go back to reference Craig ME, Kim KW, Isaacs SR, Penno MA, Hamilton-Williams EE, Couper JJ, et al. Early-life factors contributing to type 1 diabetes. Springer. 2019;62:1823–34. Craig ME, Kim KW, Isaacs SR, Penno MA, Hamilton-Williams EE, Couper JJ, et al. Early-life factors contributing to type 1 diabetes. Springer. 2019;62:1823–34.
24.
go back to reference Coton SJ, Nazareth I, Petersen I. A cohort study of trends in the prevalence of pregestational diabetes in pregnancy recorded in UK general practice between 1995 and 2012. England. 2016;6:e009494–2015. Coton SJ, Nazareth I, Petersen I. A cohort study of trends in the prevalence of pregestational diabetes in pregnancy recorded in UK general practice between 1995 and 2012. England. 2016;6:e009494–2015.
25.
go back to reference Berger H, Crane J, Farine D, Armson A, De La Ronde S, Keenan-Lindsay L et al. Screening for gestational diabetes mellitus. 2002;24:894–912. Berger H, Crane J, Farine D, Armson A, De La Ronde S, Keenan-Lindsay L et al. Screening for gestational diabetes mellitus. 2002;24:894–912.
29.
go back to reference Dabelea D, Hanson RL, Bennett PH, Roumain J, Knowler WC, Pettitt DJ. Increasing prevalence of type II diabetes in American Indian children. Germany. 1998;41:904–10. Dabelea D, Hanson RL, Bennett PH, Roumain J, Knowler WC, Pettitt DJ. Increasing prevalence of type II diabetes in American Indian children. Germany. 1998;41:904–10.
33.
go back to reference Committee DCCPGE, Feig DS, Berger H, Donovan L, Godbout A, Kader T et al. Diabetes and Pregnancy. Canada; 2018;S255–82. Committee DCCPGE, Feig DS, Berger H, Donovan L, Godbout A, Kader T et al. Diabetes and Pregnancy. Canada; 2018;S255–82.
34.
go back to reference Bowker SL, Savu A, Lam NK, Johnson JA, Kaul P. Validation of administrative data case definitions for gestational diabetes mellitus. England: Diabetes UK; 2017;34:51–5. Bowker SL, Savu A, Lam NK, Johnson JA, Kaul P. Validation of administrative data case definitions for gestational diabetes mellitus. England: Diabetes UK; 2017;34:51–5.
36.
go back to reference Berger H, Gagnon R, Sermer M. Guideline 393-diabetes in pregnancy. Elsevier. 2019;41:1814–25. e1. Berger H, Gagnon R, Sermer M. Guideline 393-diabetes in pregnancy. Elsevier. 2019;41:1814–25. e1.
38.
go back to reference Liu S, Joseph KS, Liston RM, Bartholomew S, Walker M, León JA, et al. Incidence, risk factors, and associated complications of eclampsia. LWW. 2011;118:987–94. Liu S, Joseph KS, Liston RM, Bartholomew S, Walker M, León JA, et al. Incidence, risk factors, and associated complications of eclampsia. LWW. 2011;118:987–94.
Metadata
Title
Diabetes mellitus in pregnancy across Canada
Authors
Chantal RM Nelson
Susie Dzakpasu
Aideen M. Moore
Elizabeth K. Darling
Wesley Edwards
Phil Murphy
Heather Scott
Michiel Van Den Hof
Joel G. Ray
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Pregnancy and Childbirth / Issue 1/2024
Electronic ISSN: 1471-2393
DOI
https://doi.org/10.1186/s12884-024-06534-8

Other articles of this Issue 1/2024

BMC Pregnancy and Childbirth 1/2024 Go to the issue